AK4 (A-9) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the AK4 (A-9) Antibody has been utilized in research to investigate its role in breast cancer cells, particularly in the context of drug resistance. For instance, in a study, AK4 was shown to positively regulate the expression of ATF3, which is implicated in conferring resistance to tamoxifen in MCF-7 cells, a common breast cancer cell line (liu2021).

The AK4 (A-9) Antibody is suitable for various applications including Western Blotting, ELISA, Immunofluorescence, Immunohistochemistry, and Immunoprecipitation. This versatility allows for its use in multiple experimental setups to analyze AK4 protein expression and function.

Yes, the AK4 (A-9) Antibody has been shown to react with proteins from both human and mouse sources, making it applicable for studies involving these species. This cross-reactivity is beneficial for comparative studies in different model organisms.

The AK4 (A-9) Antibody has been cited in at least five scientific articles, indicating its use and validation in various research contexts. For example, it was employed in Western Blot analysis to assess AK4 protein levels in tamoxifen-resistant MCF-7 cells, demonstrating its reliability in experimental applications (liu2021).